A Study of Imatinib and Docetaxel in Prostate Cancer

NCT00251225 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Gleevec
DRUG: Docetaxel

Sponsor

Leonard Appleman

Collaborators

[object Object]